Rationale: The transcription factor Islet-1 is a marker of cardiovascular progenitors during
embryogenesis. The isolation of Islet-1–positive (Islet-1 + ) cells from early postnatal hearts …

Rationale: Ventricular arrhythmias remain the leading cause of death in patients suffering
myocardial ischemia. Myeloperoxidase, a heme enzyme released by polymorphonuclear …

Pulmonary arterial hypertension (PAH) remains a disease with limited therapeutic options
and dismal prognosis. Despite its etiologic heterogeneity, the underlying unifying …

Aims Reduced physical activity increases the risk of heart failure; however, non‐invasive
methodologies detecting subclinical changes in myocardial function are not available. We …

Aims Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the
Fibrillin-1 gene. It is associated with formation of thoracic aortic aneurysms that can potentially …

Objective— Recruitment of immunologic competent cells to the vessel wall is a crucial step
in formation of abdominal aortic aneurysms (AAA). Innate immunity effectors (eg, …

Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. Improved
survival has led to an increasing incidence of ischemic cardiomyopathy, making it a major …

Cardiovascular disease (CVD) is the leading cause of death and accounts for one third of
disease-related mortality worldwide. Dysregulated redox mechanisms, in particular the …

In high-income countries, the presentation of tuberculosis is changing, primarily because of
migration, and understanding the specific health needs of susceptible populations is …

Nitro-fatty acids are electrophilic anti-inflammatory mediators which are generated during
myocardial ischemic injury. Whether these species exert anti-arrhythmic effects in the acute …